Atrial fibrillation is a complex condition in that its causes vary from person to person, impacting its underlying mechanisms, what triggers episodes and which treatments are effective in each individual. In addition, afib can be difficult to diagnose because it is often episodic nature and in some

A pocket hematoma is a pooling of blood around a device such as a pacemaker or implantable cardioverter defibrillator (ICD) following the implant procedure. Research led by the Ottawa Heart Institute has found that patients who experience a clinically significant pocket hematoma (CSH) are

To coincide with coverage of the Canadian Women’s Heart Health Summit, this edition of “Rapids Beats” is dedicated to news related to women and heart disease. Why Women Are Less Likely to Receive Statin Therapy Statin drugs, which lower cholesterol, are equally effective in men and women at

With enthusiasm and a shared sense of purpose, experts in women and heart disease gathered in Ottawa this April for the first Canadian Women’s Heart Health Summit. Attendees included leading figures in clinical care and research from across North America. The event aimed to lay the groundwork for

In the 1950s, available advice on women and heart health largely consisted of information on how to help husbands recover from their heart attacks. As the famous ad says, we’ve come a long way, baby. Progress is being made in addressing women’s heart health, progress that was amply demonstrated at

It was on May 11, 1976, that Phase 1 of the University of Ottawa Heart Institute opened for business. What began in 1969, as the Cardiac Unit of The Ottawa Hospital, took a major step toward becoming the internationally recognized cardiac centre that it is today. “It was a very exciting time,”